Remove Law Remove Patent Application Remove Public Domain
article thumbnail

Understanding IPO’s Rejection of UPL’s Patent Application for Mancozeb and Ortho Silicic Acid Combination in Light of the Patent Bargain and Sufficiency of Disclosure

SpicyIP

Recently, the Indian Patent Office rejected a patent application by UPL Ltd. for lack of sufficient disclosure mandated under Section 10(4) of the Patents Act. Deepali is a third-year law student at NLSIU Bangalore. Her previous posts can be accessed here.

article thumbnail

[Guest Post] CJEU weighs in on supplementary protection certificates in Merck v Teva/Clonmel decision

The IPKat

Supplementary protection certificates (SPCs) are a complex area , so it was helpful that the CJEU had the opportunity to clarify some aspects of the law. The legal framework and the relevant case law The SPC Regulation defines a 'product' in Article 1(b) as " the active ingredient or combination of active ingredients of a medicinal product."

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

A Rare Invocation for a Rare Disease?: Government Urged to Invoke Section 100, Patents Act for Rare Disease Medicine

SpicyIP

However, no details are present in the public domain. Talking about local production for Risdiplam, several patent applications are pending by manufacturers like Natco, Harman Finochem Limited, and MSN Laboratories, awaiting examination or request for examination. Another similar petition (Seba P.A

article thumbnail

Examining Oppositions: Time for a Deeper Look

SpicyIP

As some readers may have noticed, there was recently a report published by Hidayatullah National Law University, Raipur on patent oppositions. The report was also presented to DPIIT with suggestions on streamlining patent opposition process and enabling ease of doing business in India. Views expressed in the post are his own.

article thumbnail

SpicyIP Weekly Review (December 9 – December 15)

SpicyIP

Highlights of the Week Part I: Unreasoned Patent Grants and Rejections: Taking a Look at the Division Application Filing Fiasco in the BASF SE Case A Divisional Application (DA) by BASF was rejected by the IPO citing delay in filing of application. 2 in respect of the patent application of the petitioner.

article thumbnail

Combining Multiple Inventions into a Single Patent Application: Risks vs. Cost Savings

LexBlog IP

Combining Multiple Inventions in an Single Patent Application @media screen and (max-width: 1023px) {.thegem-vc-text.thegem-custom-640f87a71087f6782{display: However, is combining multiple related inventions into a single patent application worth the cost savings? important;}}@media screen and (max-width: 767px) {.thegem-vc-text.thegem-custom-640f87a71087f6782{display:

article thumbnail

Understanding Freedom to Operate (FTO) Concerning IP & Patents

Kashishipr

It implies that while a specific technology may be protected in the main markets of a company, it may lie in the public domain in some other countries. In the latter case, no license or permission of any sort is required from the patent owner for commercializing the product. Patents have a limited protection period.

IP 105